EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 52 / No 4 (December 2020) J Extra Corpor Technol, 52 4 (2020) 327-331 References
Free Access
Issue
J Extra Corpor Technol
Volume 52, Number 4, December 2020
Page(s) 327 - 331
DOI https://doi.org/10.1051/ject/202052327
Published online 15 December 2020
  1. Ramiz S, Rajpurkar M Pulmonary embolism in children. Pediatr Clin North Am. 2018;65:495–507. [CrossRef] [PubMed] [Google Scholar]
  2. Pasrija C, Kronfli A, George P, et al. Utilization of veno-arterial extracorporeal membrane oxygenation for massive pulmonary embolism. Ann Thorac Surg. 2018;105:498–504. [CrossRef] [PubMed] [Google Scholar]
  3. Maggio P, Hemmila M, Haft J, et al. Extracorporeal life support for massive pulmonary embolism. J Trauma. 2007;62:570–6. [PubMed] [Google Scholar]
  4. Dolmatova EV, Moazzami K, Cocke TP, et al. Extracorporeal membrane oxygenation in massive pulmonary embolism. Heart Lung. 2017;46:106–9. [CrossRef] [PubMed] [Google Scholar]
  5. Omar HR, Miller J, Mangar D, et al. Experience with extracorporeal membrane oxygenation in massive and submassive pulmonary embolism in a tertiary care center. Am J Emerg Med. 2013;31:1616–7. [CrossRef] [PubMed] [Google Scholar]
  6. VanderPluym CJ, Cantor RS, Machado D, et al. Utilization and outcomes of children treated with direct thrombin inhibitors on paracorporeal ventricular assist device support. ASAIO J. 2019;10:1097. [Google Scholar]
  7. He S, Blombäck M, Bark N, et al. The direct thrombin inhibitors (argatroban, bivalirudin and lepirudin) and the indirect Xa-inhibitor (danaparoid) increase fibrin network porosity and thus facilitate fibrinolysis. Thromb Haemost. 2010;103:1076–84. [CrossRef] [PubMed] [Google Scholar]
  8. Zaidi AU, Hutchins KK, Rajpurkar M Pulmonary embolism in children. Front Pediatr. 2017;5:170. [CrossRef] [PubMed] [Google Scholar]
  9. Ilich A, Noubouossie DF, Henderson M, et al. Development and application of global assays of hyper- and hypofibrinolysis. Res Pract Thromb Haemost. 2019;4:46–53. [Google Scholar]
  10. Tsantes AE, Nikolopoulos GK, Bagos PG, et al. The effect of the plasminogen activator inhibitor-1 4G/5G polymorphism on the thrombotic risk. Thromb Res. 2008;122:736–42. [CrossRef] [PubMed] [Google Scholar]
  11. Badheka A, Bangalore Prakash P, Allareddy V Successful use of extracorporeal membrane oxygenation in a child with obstructive shock due to massive bilateral pulmonary embolism. Perfusion. 2018;33:323–5. [CrossRef] [PubMed] [Google Scholar]
  12. Kolvekar SK, Peek GJ, Sosnowski AW, et al. Extracorporeal membrane oxygenator for pulmonary embolism. Ann Thorac Surg. 1997;64:883–4. [CrossRef] [PubMed] [Google Scholar]
  13. Kabrhel C, Rosovsky R, Channick R, et al. A multidisciplinary pulmonary embolism response team: Initial 30-month experience with a novel approach to delivery of care to patients with submassive and massive pulmonary embolism. Chest . 2016;150:384–93. [CrossRef] [PubMed] [Google Scholar]
  14. Penk JS, Reddy S, Polito A, et al. Bleeding and thrombosis with pediatric extracorporeal life support: A roadmap for management, research, and the future from the Pediatric Cardiac Intensive Care Society: Part 1. Pediatr Crit Care Med. 2019;20:1027–33. [CrossRef] [Google Scholar]
  15. Penk JS, Reddy S, Polito A, et al. Bleeding and thrombosis with pediatric extracorporeal life support: A roadmap for management, research, and the future from the Pediatric Cardiac Intensive Care Society: Part 2. Pediatr Crit Care Med . 2019;20:1034–9. [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.